Related Experiment Video
Updated: Oct 7, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Adequacy of probabilistic prehospital antibiotic therapy for septic shock
Romain Jouffroy1, Basile Gilbert2, Anna Hassan3
1Intensive Care Unit, University Hospital Ambroise Paré, Boulogne Billancourt, France; Intensive Care Unit, Anaesthesiology, SAMU, Necker Enfants Malades Hospital, Assistance Publique - Hôpitaux de Paris, Université de Paris, Paris, France; Centre de recherche en Epidémiologie et Santé des Populations, U1018 INSERM, Université Paris Saclay, France; Institut de Recherche bioMédicale et d'Epidémiologie du Sport - EA7329, INSEP, Université de Paris, France; EA 7525 Université des Antilles, France.
Insights
Early antibiotic therapy (ABT) in prehospital settings for septic shock (SS) is crucial. This study found that adequate prehospital ABT is frequently administered and significantly reduces 30-day mortality in SS patients.
Area of Science:
- Emergency Medicine
- Critical Care Medicine
- Infectious Diseases
Background:
- Sepsis management guidelines emphasize early recognition, diagnosis, and treatment, including prompt antibiotic therapy (ABT), to reduce septic shock (SS) mortality.
- The effectiveness and adequacy of probabilistic prehospital ABT in critically ill patients remain under-investigated.
Purpose of the Study:
- To evaluate the adequacy of probabilistic prehospital antibiotic therapy (ABT) in patients with septic shock (SS).
- To determine the association between prehospital ABT administration and 30-day mortality in SS patients managed by a mobile intensive care unit (mICU).
Main Methods:
- Retrospective analysis of consecutive patients with SS treated by a prehospital mICU intervention from May 2016 to March 2021.
- Assessment of prehospital ABT adequacy, including administered antibiotic class and timing.
- Statistical analysis using propensity score matching and inverse probability treatment weighting to evaluate the impact on 30-day mortality.
Main Results:
- Among 386 SS patients, 119 (33%) received prehospital ABT, predominantly 3rd generation cephalosporins (74%).
- No serious adverse effects were reported with prehospital ABT.
- Adequate prehospital ABT was associated with a significant reduction in 30-day mortality (aOR = 0.09 [0.01-0.47] after matching; aOR = 0.70 [0.53-0.93] with IPTW).
Conclusions:
- Probabilistic prehospital ABT is frequently adequate in SS patients managed by mICUs and is linked to decreased 30-day mortality.
- These findings suggest that prehospital ABT is a vital component of the care bundle for SS.
- Further prospective research is warranted to confirm these outcomes and solidify the role of prehospital ABT.
Background:
Guidelines on sepsis management recommend early recognition, diagnosis and treatment, especially early antibiotic therapy (ABT) administration in order to reduce septic shock (SS) mortality. However, the adequacy of probabilistic prehospital ABT remains unknown.
Methods:
From May 2016 to March 2021, all consecutive patients with SS cared for by a prehospital mICU intervention were retrospectively analyzed.
Results:
Among 386 patients retrospectively analyzed, 119 (33%) received probabilistic prehospital ABT, among which 74% received a 3rd generation cephalosporin: 31% cefotaxime and 42% ceftriaxone. No patient had a serious adverse effect related to ABT administration. Overall mortality rate on day-30 was 29%. Among the 119 patients with prehospital ABT, bacteriological identification was obtained for 81 (68%) patients with adequate prehospital ABT for 65 patients (80%) of which 10 (15%) deceased on day-30. Conversely, among the 16 (20%) patients with inadequate prehospital ABT, 9 patients (56%) were deceased on day-30. Prehospital adequate ABT was significantly different between alive and deceased patients on day-30 (p = 4.10-3). After propensity score matching, a significant association between adequate prehospital ABT administration and day-30 mortality was observed (aOR = 0.09 [0.01-0.47]). Inverse probability treatment weighting with multivariable logistic regression reported a day-30 mortality decrease in the adequate prehospital ABT group: aOR = 0.70 [0.53-0.93].
Conclusions:
Among SS cared for by a mICU, probabilistic prehospital ABT is adequate most of the time and associated with a day-30 mortality decrease. Further prospective studies are needed to confirm these results and the weight of prehospital ABT in the prehospital bundle of care for SS.
Related Concept Videos
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Acute Pyelonephritis II: Diagnostic Studies and Management
Dosage Interval and Administration Route: Determination Methods
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

